Mesenchymal Stem Cells Inhibits Migration and Vasculogenic Mimicry in Nasopharyngeal Carcinoma Via Exosomal MiR-125a
Vasculogenic mimicry (VM) is a kind of tumor vasculature providing blood supply for tumor growth, and the formation of VM is independent of vascular endothelial cells. Instead, VM structures are formed by differentiated tumor cells such as nasopharyngeal carcinoma cells. Recently, studies have shown...
Main Authors: | Fangzhu Wan, Haojiong Zhang, Jiyi Hu, Li Chen, Shikai Geng, Lin Kong, Jiade J. Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.781979/full |
Similar Items
-
A protocol for a randomized trial evaluating the role of carbon‐ion radiation therapy plus camrelizumab for patients with locoregionally recurrent nasopharyngeal carcinoma
by: Jiyi Hu, et al.
Published: (2024-02-01) -
TRIB3 promotes malignancy of head and neck squamous cell carcinoma via inhibiting ferroptosis
by: Li Chen, et al.
Published: (2024-03-01) -
Vasculogenic mimicry persists during glioblastoma xenograft growth
by: Cong Li, et al.
Published: (2018-01-01) -
Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation
by: Wanzun Lin, et al.
Published: (2023-01-01) -
Therapeutic potential of vasculogenic mimicry in urological tumors
by: Xinyu Lin, et al.
Published: (2023-09-01)